FUTURE ONCOLOGY
Volume 6 #5 April 30, 2001
State-of-the-Art in the Management of Cancer
BLADDER CANCER-PART III
TREATMENT APPROACHES IN CURRENT PRACTICE AND IN EVALUATION
Surgery
- Transurethral Resection (TUR)
- Partial (Segmented) Cystectomy
- Radical Cystectomy
- Bladder reconstruction surgery
Radiotherapy
- Radiosensitization
- Brachytherapy
Chemotherapy
- Systemic Chemotherapy
- Platinum-based chemotherapy
- Other combination regimens
- Intravesical Chemotherapy
Immunotherapy
- Intravesical Immunotherapy
- Bacillus Calmette-Guérin (BCG)
- Interferon α (IFN-α)
- Interleukin-2 (IL-2)
- Systemic Immunotherapy
Photodynamic Therapy (PDT)
Hyperthermia
Multimodality Therapy
Meeting Coverage
GENE THERAPY OF CANCER-PART I
GENE TRANSFER STRATEGIES
FROM THE 9TH INTERNATIONAL CONFERENCE
ON GENE THERAPY OF CANCER,
SPONSORED BY SIDNEY KIMMEL CANCER CENTER,
IN SAN DIEGO, CA, ON
DECEMBER 7-9, 2000
Viral Vector Systems
- Adenovirus
- Introgen Therapeutics
- Cell Genesys
- Canji
- Genphar
- Onyx Pharmaceuticals
- St. Louis University School of Medicine
- Yale University School of Medicine
- University of Arizona
- Ontario Cancer Institute
- GenVec
- Adeno-associated Virus (AAV)
- Retrovirus
- Vanderbilt University Medical Center
- King’s College London
- Lentivirus
- Herpes Simplex Virus (HSV)
- Live Poxvirus
- Loma Linda University School of Medicine
- Thomas Jefferson University
- Pseudovirion
Nonviral Gene Transfer
- Polycationic Polymers
- Baylor College of Medicine
- Valentis
- Supratek Pharma
- Cationic Lipids
- Vical
- Genzyme Molecular Oncology
- Peptide Conjugates
- Shinshu University School of Medicine
- Filamentous Bacteriophage
- Liposomal Vesicles
- Teikyo University School of Medicine
- Immunoprotective Microcapsules
- Combined Nonviral and Viral Gene Delivery
|
